Clinical Trials
112
Active:0
Completed:52
Trial Phases
5 Phases
Phase 1:16
Phase 2:6
Phase 3:41
+2 more phases
Drug Approvals
165
PHILIPPINES:129
SFDA:34
NPRA:1
+1 more agencies
Drug Approvals
BENDAMUSTINA INTAS 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
- Approval Date
- Jul 14, 2025
CIMA_AEMPS
Clinical Trials
Distribution across different clinical trial phases (98 trials with phase data)• Click on a phase to view related trials
Phase 3
41 (41.8%)Phase 4
19 (19.4%)Not Applicable
16 (16.3%)Phase 1
16 (16.3%)Phase 2
6 (6.1%)No trials found
News
CHMP Recommends Approval of Henlius and Intas' Serplulimab for ES-SCLC in Europe
The CHMP has issued a positive opinion for serplulimab (HETRONIFLY®), recommending its approval in Europe for ES-SCLC treatment.